ProStrakan delays float as Devgen bucks the trend

Wednesday 8 June 2005 at 16:00

Morgan Stanley has been forced to delay the flotation of ProStrakan due to difficulties in pricing the fledgling Scottish pharmaceuticals firm.

Warburg Pincus, the New-York based private equity firm backing ProStrakan, has already had to cut the offer price by around 25%.